Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type

ABSTRACT The association between human papillomavirus (HPV) DNA copy number and cervical disease was investigated. Viral DNA copy number for the most common high-risk HPV types in cervical cancer (types 16, 18, 31, and 45) was determined in cervical cytobrush specimens from 149 women with high-grade cervical intraepithelial neoplasias (CIN II-CIN III), 176 with low-grade CIN (CIN I), and 270 with normal cytology. Quantitative, PCR-based fluorescent assays for each of the HPV genotypes and for the β-globin gene were used. The amount of cellular DNA increased significantly with increasing disease; thus, HPV was expressed as copies per microgram of cellular DNA. The assay had a dynamic range of >107, allowing documentation for the first time of the wide range of HPV copy numbers seen in clinical specimens. Median HPV DNA copy number varied by more than 104 among the viral types. HPV16 was present in the highest copy number; over 55% of HPV16-positive samples contained more than 108 copies/μg. Median copy number for HPV16 showed dramatic increases with increasing epithelial abnormality, an effect not seen with the other HPV types. HPV16 increased from a median of 2.2 × 107 in patients with normal cytology, to 4.1 × 107 in CIN I patients, to 1.3 × 109 copies/μg in CIN II-III patients. Even when stratified by cervical disease and viral type, the range of viral DNA copies per microgram of cellular DNA was quite large, precluding setting a clinically significant cutoff value for “high” copy numbers predictive of disease. This study suggests that the clinical usefulness of HPV quantitation requires reassessment and is assay dependent.

[1]  J. Icenogle,et al.  A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA , 1997, Journal of clinical microbiology.

[2]  Daisy R. Lee,et al.  Association of human papillomavirus type 16 integration in the E2 gene with poor disease‐free survival from cervical cancer , 1997, International journal of cancer.

[3]  A. Lorincz Hybrid Capture™ Method for Detection of Human Papillomavirus DNA in Clinical Specimens: A Tool for Clinical Management of Equivocal Pap Smears and for Population Screening , 1996 .

[4]  N. Kiviat Natural history of cervical neoplasia: overview and update. , 1996, American journal of obstetrics and gynecology.

[5]  J. Best,et al.  Analytic sensitivities of hybrid‐capture, consensus and type‐specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA , 1996, Journal of medical virology.

[6]  C. Hsieh,et al.  Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction. , 1995, Journal of medical microbiology.

[7]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[8]  J. Cuzick,et al.  Semi‐quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality , 1994, British journal of obstetrics and gynaecology.

[9]  J. Cuzick,et al.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. , 1994, British Journal of Cancer.

[10]  J. Kaldor,et al.  The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.

[11]  V. Gopalakrishna,et al.  Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. , 1992, The Journal of general virology.

[12]  Steven Wolinsky,et al.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. , 1992, Human pathology.

[13]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[14]  K. Vousden,et al.  Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. , 1990, Oncogene.

[15]  P. Poletti,et al.  Papillomavirus and anal carcinoma , 1998, International Journal of Colorectal Disease.

[16]  D. Chang,et al.  Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia. , 1997, Journal of medical microbiology.

[17]  W. Reeves,et al.  Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. , 1997, American journal of obstetrics and gynecology.

[18]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[19]  K. Vousden Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .

[21]  Th. Förster Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .